Cullinan Therapeutics Inc (NASDAQ: CGEM) Recovered 22.07% From The 52-Week Low, And Now It’s -27.83% YTD – This Is What You Do Now
Cullinan Therapeutics Inc (NASDAQ:CGEM)’s traded shares stood at 0.4 million during the last session, with the company’s beta value hitting -0.07. At the close of